Shock Analytics has developed a non-invasive device for measuring systemic vascular resistance (SVR), an indicator for both congestive heart failure and sepsis.

Shock Analytics has developed a non-invasive device for measuring systemic vascular resistance (SVR), an indicator for both congestive heart failure and sepsis, two of the deadliest and most costly diseases in modern medicine. Currently, the gold standard for measuring SVR is a right heart catheterization, a very invasive and costly procedure.
Industry: Digital Health
Status: Active

Contact Information

https://shockanalyticsllc.com/

bill@shockanalyticsllc.com

Jennifer Monti

CEO

Veena Krish

CSO

Bob Harrington

CTO

Bill Bullard

COO

CFO